Gastrointestinal satiety signals in humans — Physiologic roles for GLP-1 and PYY ?

@article{Beglinger2006GastrointestinalSS,
  title={Gastrointestinal satiety signals in humans — Physiologic roles for GLP-1 and PYY ?},
  author={C. Beglinger and L. Degen},
  journal={Physiology \& Behavior},
  year={2006},
  volume={89},
  pages={460-464}
}
The present review summarizes the appetite suppressing effects of PYY and GLP-1 in the regulation of food intake in humans. Current evidence supports a role for gastrointestinal peptides as regulators of satiety. The regulation of satiety is, however, complex and it is not surprising that multiple control systems exist. It is interesting to note that nutrients in the small intestine such as hydrolysis products of fat stimulate the release of satiety peptides such as GLP-1 or PYY that serve as… Expand
Intestinal GLP-1 and satiation: from man to rodents and back
Gut induced biomarkers of appetite and satiety
Use of satiety peptides in assessing the satiating capacity of foods
Gastrointestinal targets to modulate satiety and food intake
  • M. Geraedts, F. Troost, W. Saris
  • Biology, Medicine
  • Obesity reviews : an official journal of the International Association for the Study of Obesity
  • 2011
Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
Neuroendocrine control of satiation
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential.
  • J. Holst
  • Chemistry, Medicine
  • Current medicinal chemistry
  • 1999
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.
Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans.
Gut peptides and postprandial satiety.
Inhibition of food intake in obese subjects by peptide YY3-36.
Cholecystokinin: a putative satiety signal.
...
1
2
3
4
5
...